MDxHealth (NASDAQ:MDXH – Get Free Report) and Privia Health Group (NASDAQ:PRVA – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.
Risk & Volatility
MDxHealth has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for MDxHealth and Privia Health Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| MDxHealth | 1 | 0 | 4 | 0 | 2.60 |
| Privia Health Group | 0 | 3 | 13 | 0 | 2.81 |
Earnings & Valuation
This table compares MDxHealth and Privia Health Group”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| MDxHealth | $90.05 million | 1.88 | -$38.07 million | ($0.64) | -5.59 |
| Privia Health Group | $1.74 billion | 1.64 | $14.39 million | $0.13 | 178.54 |
Privia Health Group has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares MDxHealth and Privia Health Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| MDxHealth | -30.50% | -1,078.01% | -20.05% |
| Privia Health Group | 0.89% | 2.52% | 1.47% |
Institutional and Insider Ownership
94.5% of Privia Health Group shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by company insiders. Comparatively, 10.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Privia Health Group beats MDxHealth on 11 of the 14 factors compared between the two stocks.
About MDxHealth
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
About Privia Health Group
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.
